Quick take | Washington’s fear of Chinese biotech could be just what Beijing needs

When most people think of China's export controls, they think of dual-use controls – the dramatic, headline-grabbing restrictions on critical mineral products like gallium, graphite, and most famously, rare earths. Beijing has famously deployed these levers as retaliatory weapons in… Read More »

On April 27, China's macro-planning agency, the National Development and Reform Commission (NDRC) issued a notice ordering the parties to the Meta-Manus deal to unwind the transaction. Some context: Back in January, we told readers that Beijing was clearly intending… Read More »

On December 29, Meta announced it would acquire Chinese AI startup Manus AI – reportedly for USD 2.5 billion. Inside China, the deal was widely applauded as a canonical home run: a blockbuster exit for startup founders who built a… Read More »